A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...

In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

The World Health Organization (WHO) Technical Advisory Group on COVID-19 vaccine composition, after meeting earlier this ...

New FDA framework on changes coronavirus vaccine approval will be released “in the coming days,” FDA Commissioner Marty ...

There are also now multiple years of data from people in the community who received updated COVID-19 vaccines, showing that they do protect against hospitalization. And vaccine safety monitoring ...

Adalja, MD A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked ... mRNA-1083 had an acceptable tolerability and safety profile, although adverse reactions were ...